[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
Identifieur interne : 000029 ( 2020/Analysis ); précédent : 000028; suivant : 000030[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
Auteurs : Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine]Source :
- Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica [ 1001-5302 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Médicaments issus de plantes chinoises.
- Chine, Humains, Médecine traditionnelle chinoise, Pandémies.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Drugs, Chinese Herbal.
- geographic : China.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, Humans, Medicine, Chinese Traditional, Pandemics.
Abstract
The outbreak caused by 2019 novel coronavirus(2019-nCoV) is still spreading, posing a great threat to the safety and health of general population. However, there have not been any effective drugs for treatment, with symptomatic treatment and prevention prevailing. The treatment plans of severe acute respiratory syndrome(SARS) and Middle East respiratory syndrome(MERS) are often used for reference in clinic. The advantages of traditional Chinese medicine(TCM) in treating SARS and MERS are that it can intervene and block the progression of disease in early stage, significantly reduce symptoms, shorten the treatment duration of patients, reduce complications and side effects caused by hormone therapy. The coronavirus disease 2019(COVID-19) belongs to the category of TCM epidemic diseases. Chinese patent medicines and prescriptions in medical observation and clinical treatment were recommended in the "pneumonia diagnosis and treatment plan for new coronavirus infection"(trial version fifth) of the National Health Commission of the People's Republic of China. Qingfei Paidu Decotion was recommended for the treatment of COVID-19 by the National Health Commission of the People's Republic of China and National Administration of Traditional Chinese Medicine. TCM shows good clinical efficacy and great potential in the treatment of COVID-19. Previous studies of TCM have shown broad-spectrum antiviral activity, providing a variety of sources for the discovery of new antiviral drugs. In this paper, we reviewed traditional Chinese medicines and its active ingredients in the hope of bringing novel inspirations to the drug screening and clinical treatment for COVID-19.
DOI: 10.19540/j.cnki.cjcmm.20200219.501
PubMed: 32281335
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000209
- to stream PubMed, to step Curation: 000209
- to stream PubMed, to step Checkpoint: 000012
- to stream Ncbi, to step Merge: 003911
- to stream Ncbi, to step Curation: 003911
- to stream Ncbi, to step Checkpoint: 003911
- to stream Main, to step Merge: 000028
- to stream Main, to step Curation: 000029
- to stream Main, to step Exploration: 000029
- to stream 2020, to step Extraction: 000029
Links to Exploration step
pubmed:32281335Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].</title><author><name sortKey="Zhang, Yu Shi" sort="Zhang, Yu Shi" uniqKey="Zhang Y" first="Yu-Shi" last="Zhang">Yu-Shi Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author><author><name sortKey="Cong, Wei Hong" sort="Cong, Wei Hong" uniqKey="Cong W" first="Wei-Hong" last="Cong">Wei-Hong Cong</name><affiliation wicri:level="1"><nlm:affiliation>Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100091</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, Jing Jing" sort="Zhang, Jing Jing" uniqKey="Zhang J" first="Jing-Jing" last="Zhang">Jing-Jing Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author><author><name sortKey="Guo, Fei Fei" sort="Guo, Fei Fei" uniqKey="Guo F" first="Fei-Fei" last="Guo">Fei-Fei Guo</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author><author><name sortKey="Li, Hong Mei" sort="Li, Hong Mei" uniqKey="Li H" first="Hong-Mei" last="Li">Hong-Mei Li</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32281335</idno><idno type="pmid">32281335</idno><idno type="doi">10.19540/j.cnki.cjcmm.20200219.501</idno><idno type="wicri:Area/PubMed/Corpus">000209</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000209</idno><idno type="wicri:Area/PubMed/Curation">000209</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000209</idno><idno type="wicri:Area/PubMed/Checkpoint">000012</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000012</idno><idno type="wicri:Area/Ncbi/Merge">003911</idno><idno type="wicri:Area/Ncbi/Curation">003911</idno><idno type="wicri:Area/Ncbi/Checkpoint">003911</idno><idno type="wicri:doubleKey">1001-5302:2020:Zhang Y:research:progress:of</idno><idno type="wicri:Area/Main/Merge">000028</idno><idno type="wicri:Area/Main/Curation">000029</idno><idno type="wicri:Area/Main/Exploration">000029</idno><idno type="wicri:Area/2020/Extraction">000029</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].</title><author><name sortKey="Zhang, Yu Shi" sort="Zhang, Yu Shi" uniqKey="Zhang Y" first="Yu-Shi" last="Zhang">Yu-Shi Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author><author><name sortKey="Cong, Wei Hong" sort="Cong, Wei Hong" uniqKey="Cong W" first="Wei-Hong" last="Cong">Wei-Hong Cong</name><affiliation wicri:level="1"><nlm:affiliation>Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100091</wicri:noRegion></affiliation></author><author><name sortKey="Zhang, Jing Jing" sort="Zhang, Jing Jing" uniqKey="Zhang J" first="Jing-Jing" last="Zhang">Jing-Jing Zhang</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author><author><name sortKey="Guo, Fei Fei" sort="Guo, Fei Fei" uniqKey="Guo F" first="Fei-Fei" last="Guo">Fei-Fei Guo</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author><author><name sortKey="Li, Hong Mei" sort="Li, Hong Mei" uniqKey="Li H" first="Hong-Mei" last="Li">Hong-Mei Li</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700</wicri:regionArea><wicri:noRegion>China Academy of Chinese Medical Sciences Beijing 100700</wicri:noRegion></affiliation></author></analytic><series><title level="j">Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica</title><idno type="ISSN">1001-5302</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus</term><term>China</term><term>Coronavirus Infections (drug therapy)</term><term>Drugs, Chinese Herbal (therapeutic use)</term><term>Humans</term><term>Medicine, Chinese Traditional</term><term>Pandemics</term><term>Pneumonia, Viral (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Chine</term><term>Humains</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Médecine traditionnelle chinoise</term><term>Médicaments issus de plantes chinoises (usage thérapeutique)</term><term>Pandémies</term><term>Pneumopathie virale (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Drugs, Chinese Herbal</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Médicaments issus de plantes chinoises</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Humans</term><term>Medicine, Chinese Traditional</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Chine</term><term>Humains</term><term>Médecine traditionnelle chinoise</term><term>Pandémies</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The outbreak caused by 2019 novel coronavirus(2019-nCoV) is still spreading, posing a great threat to the safety and health of general population. However, there have not been any effective drugs for treatment, with symptomatic treatment and prevention prevailing. The treatment plans of severe acute respiratory syndrome(SARS) and Middle East respiratory syndrome(MERS) are often used for reference in clinic. The advantages of traditional Chinese medicine(TCM) in treating SARS and MERS are that it can intervene and block the progression of disease in early stage, significantly reduce symptoms, shorten the treatment duration of patients, reduce complications and side effects caused by hormone therapy. The coronavirus disease 2019(COVID-19) belongs to the category of TCM epidemic diseases. Chinese patent medicines and prescriptions in medical observation and clinical treatment were recommended in the "pneumonia diagnosis and treatment plan for new coronavirus infection"(trial version fifth) of the National Health Commission of the People's Republic of China. Qingfei Paidu Decotion was recommended for the treatment of COVID-19 by the National Health Commission of the People's Republic of China and National Administration of Traditional Chinese Medicine. TCM shows good clinical efficacy and great potential in the treatment of COVID-19. Previous studies of TCM have shown broad-spectrum antiviral activity, providing a variety of sources for the discovery of new antiviral drugs. In this paper, we reviewed traditional Chinese medicines and its active ingredients in the hope of bringing novel inspirations to the drug screening and clinical treatment for COVID-19.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhang, Yu Shi" sort="Zhang, Yu Shi" uniqKey="Zhang Y" first="Yu-Shi" last="Zhang">Yu-Shi Zhang</name></noRegion><name sortKey="Cong, Wei Hong" sort="Cong, Wei Hong" uniqKey="Cong W" first="Wei-Hong" last="Cong">Wei-Hong Cong</name><name sortKey="Guo, Fei Fei" sort="Guo, Fei Fei" uniqKey="Guo F" first="Fei-Fei" last="Guo">Fei-Fei Guo</name><name sortKey="Li, Hong Mei" sort="Li, Hong Mei" uniqKey="Li H" first="Hong-Mei" last="Li">Hong-Mei Li</name><name sortKey="Zhang, Jing Jing" sort="Zhang, Jing Jing" uniqKey="Zhang J" first="Jing-Jing" last="Zhang">Jing-Jing Zhang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000029 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000029 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32281335
|texte= [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32281335" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |